Huntington lab news
Behind every treatment that improves human health is a story of discovery. Every day we make new research discoveries and forge partnerships that have a global impact.
News and outreach highlights
Professor Huntington is willing to talk to the media about his research discoveries to date.
- oNKo-Innate joins forces with Gilead Sciences and its subsidiary Kite to discover and develop cancer immunotherapies focused on natural killer (NK) cells. https://www.fiercebiotech.com/biotech/gilead-kite-pen-natural-killer-pact-little-known-australian-cell-therapy-player
- Professor Huntington’s breakthrough discovery that Cish acted as a ‘checkpoint’ or switch that shutdown the ability of NK cells to become activated, and inhibiting Cish function alone was more effective than the current gold-standard immunotherapies that have revolutionised cancer outcomes earned him the 2019 Jacques Miller Media for experimental biomedicine, Australian Academy of Science, February 2019
Monash BDI news
With 700 researchers making incredible discoveries daily, Monash BDI has many success stories to share.